English  |  正體中文  |  简体中文  |  Items with full text/Total items : 28351/40344
Visitors : 4102954      Online Users : 123
RC Version 4.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Adv. Search

Please use this identifier to cite or link to this item: http://ntour.ntou.edu.tw:8080/ir/handle/987654321/9891

Title: 抗精神病藥物抑制Adiponectin基因表現及分泌機制之探討
The Inhibitory Effect of Antipsychitics on the Mechanisms of Adiponectin Gene Expression and Secretion
Authors: 陳秀儀
Contributors: NTOU:Institute of Bioscience and Biotechnology
Date: 2009-08
Issue Date: 2011-06-28T07:17:50Z
Publisher: 行政院國家科學委員會
Abstract: 摘要:現今臨床使用的第二代抗精神病藥物(又稱非典型抗精神病藥物)易造 成體重增加,使精神病患易罹患糖尿病、心血管疾病及其它的併發症。目 前對於抗精神病藥物引發體重增加機制並不清楚。由於肥胖者血清中 adiponectin 濃度較瘦者來得低,且研究顯示血清中低adiponectin 易造成胰 島素阻抗性及增加冠狀動脈硬化的罹患率。然而adiponectin 與抗精神病藥 物之相關研究非常缺乏,為了解是否adiponectin 與抗精神病藥物引發體重 增加是否具相關性,本實驗室先前在臨床上針對體重過重之精神病患換成 低體重增加量的抗精神病藥物amisulpride 一年間,偵測病患血清中 adiponectin 濃度,結果adiponectin 濃度增加與體重及腰圍的變化呈現負相 關,即病患換藥後體重減輕,血清中adiponectin 增加。在基礎研究部分, 我們證實易造成體重增加的抗精神病藥物可直接抑制脂肪細胞的 adiponectin 基因表現及分泌,而抗精神病藥物amisulpride 並不會抑制脂肪 細胞分泌adiponectin。此外,我們初步結果也證實,易造成體重增加的抗精 神病藥物可促進前脂肪細胞之分化造成脂質堆積及抑制脂肪細胞 adiponectin 基因表現,其機制可能是經由adipoR2,adipoR2 途徑主要涉及 壓力及發炎反應,因而在此假設(1) 抗精神病藥物改變脂肪細胞代謝能 力,抑制adiponectin 基因表現及分泌;(2) 抗精神病藥物透過壓力及發炎 反應抑制adiponectin 基因表現及分泌。 目前並無文獻探討抗精神病藥物對adiponectin 基因表現與分泌的調控 之相關研究,本計劃擬從二方面先探討抗精神病藥物抑制adiponectin 基因 表現與分泌之機制; (1)抗精神病藥物是否透過影響脂肪細胞老化、粒線 體生成及其功能,抑制adiponectin 的基因表現和分泌;(2) 抗精神病藥物 是否透過缺氧(hypoxia) 、過氧壓力(oxidative stress) 、內質網壓力 (endoplasmic reticulum stress)及發炎反應(inflammation)而抑制adiponectin 的基因表現和分泌。 由於adiponectin 具抗糖尿病、冠狀動脈硬化及發炎反應等特性,此計 劃有助於了解抗精神病藥物對adiponectin 基因表現與分泌之抑制之相關 機制,作為未來研究臨床精神用藥及藥物開發之參考。
Abstract:Second-generation antipsychotics (also called atypical antipsychotics) have the vulnerability of the side effect of weight gain. Patients taking these medicines raise the risk of getting diabetes, cardiovascular and other co-morbid diseases. Adiponectin levels are lower in obese than lean subjects Several studies demonstrated hypoadiponectin can induce insulin resistance and increase risk for atherosclerotic diseases. However, the related researches between antipsychotics and adiponectin remains poorly characterized. To study whether adiponectin is associated with antipsychotic-induced weight gain, we recruited chronic psychotic inpatients with overweight and evaluate the change in adiponectin after switching to low weight gain antipsychotics from taking other antisychotics for one year. A negative correlation was found between adiponectin, and body weight and waist circumference, respectively. Our preliminary results demonstrated that antipsychotics with high weight gain effect can directly inhibit adiponectin gene expression and secretion, but not amisulpride. Besides, we also demonstrated that antipsychoyics promoted adipocyte differentiation, fat accumulation and inhibited adiponectin gene expression which is involved in stress and inflammation via adipoR2 in adipocyte. Based on our preliminary findings, we hypothesize that (1) antipychotics inhibit adiponectin gene expression and secretion through change of capacity of adipocyte metabolism ; (2) antipychotics inhibit adiponectin gene expression and secretion through stress and inflammation. At present, no paper discusses the effect of antipsychotics on regulation of adiponectin gene expression and secretion. Regulation of adiponectin gene expression and secretion is very complex. Based on present data, antipsychotics promote fat accumulation and adiponectin gene regulation involved in stress and inflammation.To explore the inhibitory effect of antipsychotics on adiponectin gene expression and secretion, we plan he following goals in the next two years below: .Elucidate whether antipychotics inhibit adiponectin gene expression and secretion through adipocyte aging and mitochondrial biogenesis and mitochondrial dysfunction. .Elucidate whether antipychotics inhibit adiponectin gene expression and secretion through hypoxia, oxidative stress, endoplasmic reticulum stress and inflammation. Because adiponectin owns antidiabetic, antiatherogenic and anti-inflammatory properties, we believe these approaches outlined above may help understand the inhibitory effect of antipsychotics on adipocyte and adiponectin gene expression and secretion of adipocytes. It may have implications for further researches in clinical practice of antipsychotic medications and antipsychotic drug development.
Relation: NSC98-2320-B019-002
URI: http://ntour.ntou.edu.tw/ir/handle/987654321/9891
Appears in Collections:[生命科學暨生物科技學系] 研究計畫

Files in This Item:

There are no files associated with this item.

All items in NTOUR are protected by copyright, with all rights reserved.


著作權政策宣告: 本網站之內容為國立臺灣海洋大學所收錄之機構典藏,無償提供學術研究與公眾教育等公益性使用,請合理使用本網站之內容,以尊重著作權人之權益。
網站維護: 海大圖資處 圖書系統組
DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback